A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth

References

• MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev200456218522915169927
   PubMed Web of Science ®Google Scholar
• MuggiaFMSpeyerJLDoxorubicin-induced cardiomyopathyN Engl J Med19993408654655
   PubMedGoogle Scholar
• SwainSMWhaleyFSEwerMSCongestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trialsCancer200397112869287912767102
   PubMed Web of Science ®Google Scholar
• ChatterjeeKZhangJHonboNKarlinerJSDoxorubicin cardiomyopathyCardiology2010115215516220016174
   PubMed Web of Science ®Google Scholar
• EwerMSEwerSMCardiotoxicity of anticancer treatments: what the cardiologist needs to knowNat Rev Cardiol201071056457520842180
   PubMed Web of Science ®Google Scholar
• MohajeriMSahebkaAProtective effects of curcumin against doxorubicin-induced toxicity and resistance: a reviewCrit Rev Oncol Hematol2018122305129458788
   PubMed Web of Science ®Google Scholar
• OlsonRDMushlinPSBrennerDEDoxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolProc Natl Acad Sci U S A19888510358535892897122
   PubMed Web of Science ®Google Scholar
• PereiraGCSilvaAMDiogoCVCarvalhoFSMonteiroPOliveiraPJDrug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilolCurr Pharm Des201117202113212921718248
   PubMed Web of Science ®Google Scholar
• OjhaSTaeeHAGoyalSCardioprotective potentials of plant-derived small molecules against doxorubicin associated cardiotoxicityOxid Med Cell Longev20162016572497327313831
   PubMed Web of Science ®Google Scholar
• AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends Pharmacol Sci2008302859419110321
   PubMed Web of Science ®Google Scholar
• BenzerFKandemirFMOzkaracaMKucuklerSCaglayanCCur-cumin ameliorates doxorubicin-induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in ratsJ Biochem Mol Toxic2018322e22030
   Web of Science ®Google Scholar
• YallapuMMJaggiMChauhanSCCurcumin nanoformulations: a future nanomedicine for cancerDrug Discov Today2012171–2718021959306
   PubMed Web of Science ®Google Scholar
• FanXZhangCLiuDBYanJLiangHPThe clinical applications of curcumin: current state and the futureCurr Pharm Des201319112011203123116310
   PubMed Web of Science ®Google Scholar
• MaWGuoQLiYCo-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacyEur J Pharm Biopharm201611220922327913127
   PubMed Web of Science ®Google Scholar
• GuYLiJLiYNanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancerInt J Nanomed20161157575770
   PubMed Web of Science ®Google Scholar
• WangJMaWTuPSynergistically improved anti-tumor efficacy by co-delivery doxorubicin and curcumin polymeric micellesMacromol Biosci20151591252126125981672
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBKanuBGSmart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive reviewJ Control Release201725822625328472638
   PubMed Web of Science ®Google Scholar
• SundaramoorthyPRamasamyTMishraSKEngineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cellsActa Biomater20164222023127395829
   PubMed Web of Science ®Google Scholar
• RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
   PubMed Web of Science ®Google Scholar
• RuttalaHBRamasamyTMadeshwaranTEmerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applicationsArch Pharm Res201841211112929214601
   PubMed Web of Science ®Google Scholar
• LiuHXuHJiangYXPreparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targetingInt J Nanomedicine2015106395641026504386
   PubMed Web of Science ®Google Scholar
• WangBLShenYZhangQCodelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancerInt J Nanomedicine201383521353124101869
   PubMedGoogle Scholar
• JiangYWangFXuHLiuHMengQLiuWDevelopment of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlationInt J Pharm20144751–247548425219858
   PubMedGoogle Scholar
• WangHBYuPFGouHTCardioprotective effects of 20(S)-ginsenoside Rh2 against doxorubicin-induced cardiotoxicity in vitro and in vivoEvid Based Complement Alternat Med2012201250621423125868
   PubMed Web of Science ®Google Scholar
• LvGYSunDJZhangJWLx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivoActa Pharm Sin B201771525828119808
   PubMed Web of Science ®Google Scholar
• ManjuSSreenivasanKSynthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugateJ Pharm Sci2011100250451120848656
   PubMed Web of Science ®Google Scholar
• ZhangDXuQLiuKXuHComparison of pharmacokinetics of curcumin in rats administered with two kinds of polymeric micellesZhongguo Zhong Yao Za Zhi201641193668367328925166
   PubMedGoogle Scholar
• JaequetJMBressolleFGaltierMDoxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parametersCancer Chemother Pharmacol19902732192252265458
   PubMed Web of Science ®Google Scholar
• RuggieroADeRGRizzoDMyocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemiaInt J Clin Oncol20131892793322911020
   PubMed Web of Science ®Google Scholar
• JorgensenWLMaxwellDSTiradorivesJDevelopment and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquidsJ Am Chem Soc19961181122511236
   Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
   PubMed Web of Science ®Google Scholar
• NamdariMEatemadiACardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell linesArtif Cells Nanomed Biotechnol201745473173927924631
   PubMed Web of Science ®Google Scholar
• GustafsonDLRastatterJCColomboTLongMEDoxorubicin pharmacokinetics: macromolecule binding, metabolism, and excretion in the context of a physiologic modelJ Pharm Sci20029161488150112115848
   PubMed Web of Science ®Google Scholar
• SchrijversDRole of red blood cells in pharmacokinetics of chemotherapeutic agentsClin Pharmacokinet200342977979112882586
   PubMed Web of Science ®Google Scholar
• LiCChoiBCKimDKEffects of curcumin on the pharmacokinetics of loratadine in rats: possible role of CYP3A4 and p-glycoprotein inhibition by curcuminBiomol Ther201119364370
   Web of Science ®Google Scholar
• MennaPRecalcatiSCairoGMinottiGAn introduction to the metabolic determinants of anthracycline cardiotoxicityCardiovasc Toxicol200772808517652809
   PubMed Web of Science ®Google Scholar
• HeibeinADGuoBSprowlJARole of aldoketo reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localizationBMC Cancer20121238139522938713
   PubMed Web of Science ®Google Scholar